These rare event CASE reports describe the recognition or treatment of conditions that are both rare in the physically active population and potentially life or limb threatening. Instructions to authors for case reporting are limited: Validation CASE reports are the application of the best available external evidence. This demonstrates the need for clinician input—the need for the best practices and clinical effectiveness to serve as directions for future clinical research. Exploration CASE series present compelling, practice-based unique evidence across multiple patients.
The rare event case study is an avenue for providing this information in order to teach something new or to offer a refresher to others. For outcomes that were considerably different, interpretations of these divergences were discussed. A main objective for these cases is to provide evidence of the importance of the AT as a member of an interprofessional health care team in managing a rare condition and making clinical decisions. In the broader medical literature, case studies provide a medium for describing new conditions, their potential etiologic factors, prognostic timelines, and potentially advantageous therapeutic strategies. No matter how alike 2 athletes appear, each has unique characteristics: The levels also help to characterize the rigor of the evidence that can be derived from each type of Clinical CASE Report. The P and the I stay relatively the same; the C and O are where the revision makes sense.
In summary, this new paradigm helps to tie together the best clinical practices, professional education, and research investigations through the common lens of Cwse and PBE.
Clinical Case Study as a Clinical Communication Tool
A clinician was confronted with a rehabilitation problem. To support the enhanced importance of the case study, a comprehensive and descriptive model for 1 defining the nature of uniqueness and 2 generating a hierarchy of Clinical CASE Reports within the validation and exploration structure was needed. Typical presentations of prognoses, diagnoses, therapeutic strategies, etc, are hallmarks of these manuscripts. The comparison that guides all of these levels is with outcomes within the external evidence that currently exists.
Further, clinical communication is enhanced when we go beyond the unusual diagnosis. Evidence-based practice or practice-based evidence: Position statements and clinical practice guidelines would also be considered high-level sources to be validated. This clinician took care to determine the similarities between the current patient and the study participants. Key features of the athlete’s specific case, the taping technique that allowed the athlete to fully participate symptom free, and discussion of the outcomes of this case would be expected.
Clinical Contributions to the Available Sources of Evidence (CASE) Reports: Executive Summary
The levels also help to characterize the rigor of the evidence that can be derived from each type of Clinical CASE Report. The purpose of validation CASE reports is to test the results of published external evidence in an actual clinical environment on an individual patient.
Strength caxe the Evidence To support the enhanced importance of the case study, a comprehensive and descriptive model for 1 defining the nature of uniqueness and 2 generating a hierarchy of Clinical CASE Reports within the validation and exploration structure was needed. Building a case for case studies. When valued, both EBP and PBE contribute to greater understanding and a richer evidence-based body of knowledge, and perhaps more importantly, help to close the ever-widening gap between the clinic and the research laboratory.
Table of Contents
Far too much significance is typically placed on the unusual diagnosis, almost to the exclusion of other sources of clinical evidence. Systematic guidelines, recommendations, or reporting requirements were inconsistent or nonexistent in the scientific health case study literature. Classification Evidence-based sttudy Practice-based evidence Practice-based evidence Practice-based evidence.
We have opted to better define the term to provide some standardization for the unique clinical exploration case. Provide a framework for advancing the current perspectives for the key features associated with the condition of interest and warrants at least investigation at the next level of evidence case series Level 4: These rare event 7 CASE reports would afford clinicians information regarding a condition that may be dase to ATs but may not currently be found specifically within the athletic training ijatg of knowledge.
Exploration CASE series present compelling, practice-based unique evidence across multiple patients. This paradigm supports the role of the case study and defines the significance of clinical contributions to the available sources of evidence and the body of knowledge at large. Clinicians also recognize when the best available research evidence does not necessarily work in real life.
Lastly, for validation CASE reports, the comparative outcome is in reference to the previously published study that is the original source being assessed. We sfudy the opportunity to enhance the value of case studies by not only introducing what might be novel PBE 4 but also confirming or refining our EBP. For example, the progress of the Journal of Athletic Training JAT has been deliberate, with tremendous dedication, vision, and leadership.
Additionally, a detailed explanation of author guidelines has been provided http: An essential component of the exploration CASE report is the reporting of the critical key feature s that led to the clinical decisions and outcomes. After searching the best available evidence, the clinician decided to use evidence from a published randomized controlled trial.
Each type of Clinical CASE Report provides a different level of evidence, allowing each to contribute to the body of literature in a unique and valuable fashion. Two important discussion points should be considered and provided in rare event CASE reports: In other words, what happens next?
Based on this example although it is not uniqueATs should recognize vital information that is relevant and important to clinical practice. This additional information is critical and expands our understanding of these rare conditions and of how ATs can casf prepare for future instances.
No matter how alike 2 athletes appear, each has unique characteristics: